Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.
Milani P, Sanna GD, Mussinelli R, Basset M, Guida G, Attanasio A, Nanci M, Fabris F, Bellofiore C, Fogliani A, Novello E, Benigna F, Obici L, Benvenuti P, Ciardo M, Nuvolone M, Averaimo M, Casu G, Foli A, Perlini S, Merlini G, Palladini G. Milani P, et al. Among authors: benigna f. J Am Heart Assoc. 2024 Dec 24:e036755. doi: 10.1161/JAHA.124.036755. Online ahead of print. J Am Heart Assoc. 2024. PMID: 39719432 Free article.
Development and Validation of Staging Systems for AA Amyloidosis.
Basset M, Schönland SO, Obici L, Günther J, Riva E, Dittrich T, Milani P, Ferretti VV, Pasquinucci E, Foli A, Kimmich C, Nanci M, Bellofiore C, Benigna F, Beimler J, Benvenuti P, Fabris F, Mussinelli R, Nuvolone M, Klersy C, Albertini R, Merlini G, Hegenbart U, Palladini G, Blank N. Basset M, et al. Among authors: benigna f. J Am Soc Nephrol. 2024 Jun 1;35(6):782-794. doi: 10.1681/ASN.0000000000000339. Epub 2024 Mar 21. J Am Soc Nephrol. 2024. PMID: 38512269
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients.
Basset M, Milani P, Ferretti VV, Nuvolone M, Foli A, Benigna F, Nanci M, Bozzola M, Ripepi J, Sesta M, Russo F, Bosoni T, Klersy C, Albertini R, Merlini G, Palladini G. Basset M, et al. Among authors: benigna f. Clin Chem Lab Med. 2022 Jan 13;60(3):386-393. doi: 10.1515/cclm-2021-0912. Print 2022 Feb 23. Clin Chem Lab Med. 2022. PMID: 35018751 Free article.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate.
Milani P, Fazio F, Basset M, Berno T, Larocca A, Foli A, Riva M, Benigna F, Oliva S, Nuvolone M, Rodigari L, Petrucci MT, Merlini G, Palladini G. Milani P, et al. Among authors: benigna f. Am J Hematol. 2020 Aug;95(8):900-905. doi: 10.1002/ajh.25828. Epub 2020 Apr 30. Am J Hematol. 2020. PMID: 32282971 Free article.